Where years of life come from – Simon Wilcock

“Perhaps someone should let the minister know that a quarter of a century of additional life expectancy has been granted to each Australian since the Anzacs landed at Gallipoli, and health analysts clearly attribute most of the improvement to fundamental increases in standards of living (eg, housing, sanitation and health literacy), basic preventive measures such as vaccination, and an improved identification and management of chronic disease within community-based health services.”

Simon Wilcock

http://www.australiandoctor.com.au/opinions/guest-editorial/time-to-freshen-up-the-health-reform-script

Time to freshen up the health reform script

comments

mous long-running soap opera starts each episode with the doleful announcement that “like sands through the hourglass, so are the days of our lives”.

In Australia in 2015, we could modernise the prologue by saying “another health minister, another review of Medicare”.

As with the soapie, we are likely to see the same cast of stock characters play out the same plots, with the same outcomes.

In the face of irrefutable evidence, we cling to a model of healthcare that remains resolutely resistant to change.

Related Opinion:

The term ‘white elephant’ comes from the ancient Indian tradition of gifting such a beast to your troublesome vassals in the knowledge that the cost of keeping such a wonderful creature would bankrupt said vassal and leave them without the resources to seriously challenge you.

The Australian public has been led to believe that hospital beds are the currency of health GDP in this country.

But in many respects, each new bed is simply another white elephant — an insatiable and bottomless pit in terms of the funding needed to maintain it, and firmly anchored in a reactive healthcare system steadfastly resistant to change.

Related News:

Last month’s announcement by Federal Health Minister Sussan Ley of a comprehensive review of Medicare would be welcome if we could be confident that any recommendations would translate into sensible action.

A week earlier, we learned from the leaked National Mental Health Commission report that respected economist Professor Allan Fels, who chaired the commission, had recommended a large-scale shift in funding from hospitals to GPs and the community, but neither the report nor the recommendation appear destined for adoption, with Ms Ley ruling out shifting the suggested $1 billion in mental health funding from secondary to primary and community care.

Perhaps someone should let the minister know that a quarter of a century of additional life expectancy has been granted to each Australian since the Anzacs landed at Gallipoli, and health analysts clearly attribute most of the improvement to fundamental increases in standards of living (eg, housing, sanitation and health literacy), basic preventive measures such as vaccination, and an improved identification and management of chronic disease within community-based health services.

The message is clear. As a profession, we remain committed to alleviating the suffering of those who are acutely ill, but increased investment in health services at a preventive and primary care level will result in a better return for every dollar invested in health.

Professor Fels’ recommendations simply add to what is already a strong evidence base for the need to reform our health funding allocations.

Yet Minister Ley’s announcement of the Medicare review stops short of acknowledging the issue of an underfunded community health sector, including general practice.

The establishment of a primary health care advisory group is a positive move.

The minister has consulted widely and appears to understand the drivers in healthcare, but the current government has so far shown little commitment to nurturing primary healthcare, instead freezing Medicare rebates, reducing overall funding to the new Primary Health Networks and significantly disrupting general practice training systems.

We know that there is unlikely to be significant additional funding injected into the health sector.

In our current economic situation, we must accept this as a prudent and pragmatic position, but without commitment to act on what is clear evidence of the need for reform, it is hard to be optimistic that policymakers will embrace change.

The current healthcare script in this country is unidimensional, with hospital beds inevitably cast in the leading role, and any attempt to control their growth reported as a villainous act.

Any change in the public perception will require vision and collaboration, but it is surely time to give the audience a new story.

Professor Willcock is professor of general practice at the University of Sydney.

Health Evolution Summit – Overview

 

http://www.healthevolutionsummit.com/Default.aspx?PageID=16199729

1:00 pm – 2:15 pm

Pre-Summit Sessions (concurrent)

CEOs of leading providers/payers share their outlook on their critical innovation priorities and highlight respective approaches to vet solutions. A variety of provider/payer executives then connect with innovative CEOs from relevant service, IT and product companies to learn about new solutions and provide insights on the solutions’ value to the market.

Pavillions IV & V

Payer Connect: Where payer executives and innovative CEOs meet

Select health plan CEOs will share their strategic forecasts and the critical innovations necessary to remain competitive in a dynamic market. Payer executives and CEOs of relevant health service, IT and product companies will network briefly to share ideas and make a plan to reconnect pending mutual benefit.

Moderator:
Mike Gaffney, Co-Founder and Managing Director, EDG Partners

Speakers:
Dan Hilferty, President and CEO, Independence Blue Cross
Steve S. Martin, President and CEO, Blue Cross and Blue Shield of Nebraska, Summit Chair

Networking tables will be hosted by:
Aetna – Bjorn Thaler, VP, Head of Corporate Development
Blue Cross & Blue Shield of Nebraska – Steve S. Martin, CEO and Lew Trowbridge, President and Chief Operating Officer
Blue Cross & Blue Shield of North Carolina – Andy Brynes, VP, Strategic Development, Mosaic Health Solutions
Cambia Health Solutions – Ben Albert, Operating Partner, Rob Coppedge, SVP Strategic Investment & Corporate Development
Highmark Health – Nanette DeTurk, EVP, Chief Administrative and Strategy Officer and Treasurer
Independence Blue Cross – Terry Booker, VP of Corporate Development and Innovation, and Tom Olenzak, Managing Director Strategic Innovation Portfolio

Salons I & II

Provider Connect: Where provider executives and innovative CEOs meet

Select provider CEOs will share their strategic forecasts and the critical innovations necessary for their organizations to remain relevant and competitive. Provider executives and CEOs of relevant health service, IT and product companies will briefly network to share ideas and make a plan to reconnect pending mutual benefit.

Moderator:
Robert Wah, MD, Chief Medical Officer, CSC; President, AMA

Speakers:
John Brooks, President and CEO, Joslin Diabetes Center
John D. Doyle, President and CEO, Ascension Holdings
Michael Wagner, MD, FACP, President and CEO, Tufts Medical Center

Networking tables will be hosted by:
Dignity Health – Richard Roth, Chief Strategic Innovation Officer
Hospital Corporation of America – Chip Blaufuss, AVP of Strategic Innovation
Kaiser Permanente – Chris Stenzel, VP of Business Development and Innovation
Stanford Health Care – Kash Kapadia, VP and General Manager, Digital Health
Sutter Health – Peter Anderson, Chief Strategy Officer
Swedish Medical Group – Ralph Pascualy, Chief Executive

2:15 pm – 3:15 pm
The Monarch Bay Sunset Terrace

Alumni Reception

Before the Summit begins, relax and reconnect with fellow alumni. All Summit alumni welcome to attend.

2:15 pm – 3:15 pm
Monarch Pool Terrace

First-Time Participant Welcome

Meet fellow first-time Summit participants. All first-time Summit participants welcome.

General Session: Emerging (and Decaying) Models

The Summit explores the macro implications of emerging (and decaying) models in health and the micro implications that flow from them through a lens that cuts across traditional industry lines of health care services, health IT and life science. Sessions explore the economic underbelly of big issues in search of sustainable business models, directional opportunities and Beachheads.

3:30 pm – 3:45 pm
Salons III & IV

Opening Comments

Patrick Geraghty, Chairman and CEO, GuideWell and Florida Blue, Summit Chair
Ann H. Lamont, Managing Partner, Oak HC/FT Partners, Summit Innovation Chair
Charlie Martin, Chairman and CEO, Martin Ventures
Julie Murchinson, CEO, Health Evolution Summit

3:45 pm – 4:30 pm
Salons III & IV

A Perspective with Steve Hemsley

Interviewer:
Todd Cozzens, Partner, Sequoia Capital, Summit Innovation Chair

Speaker:
Steve Hemsley, CEO, UnitedHealth Group

Building the Business Case for High-Priced Therapeutics

Specialty drugs in the U.S. now comprise more than 25% of total pharmaceutical spend and the annual cost per patient can be as high as $100,000 per year. By 2020, the cost of specialty drugs is projected to quadruple and cost the nation more than $400 billion. Is the high-priced approach the new business model for innovation? Are there economically rational reimbursement approaches for certain high-costs diseases? Leaders with high stakes in the game will explore these trade-offs, emerging approaches and financing mechanisms.

Moderator:
Arnold Milstein, MD, MPH, Professor of Medicine, Director of Clinical Excellence Research Center, Stanford University

Speakers:
Joshua Ofman, MD, MSHS, SVP, Global Value and Access and Policy, Amgen
Tim Wentworth, President, Express Scripts

5:20 pm – 6:00 pm
Salons III & IV

The Consumer-Engaged Enterprise

To both attract and retain customers, even the most well-established, integrated delivery networks are striving to re-engineer their approach to consumer-centric convenience and service. Meanwhile, newer companies are striving to demonstrate an entirely new level of consumer experience with tools and delivery models that speak to consumer interests. Hear from an established integrated delivery system and a novel primary care model on what is working and where they are headed.

Moderator:
Brad Fluegel, Chief Strategy and Business, Development Officer, Walgreens Boots Alliance,Summit Partner Committee

Speakers:
Rushika Fernandopulle, MD, MPP, CEO and Co-Founder, Iora Health
Glenn D. Steele Jr., MD, PhD, President and CEO, Geisinger Health System

6:00 pm – 9:00 pm
Dana Lawn

Welcome Event

Dinner served

9:00 pm – 11:00 pm
The Terrace Salon Balcony

Après Dessert and Digestifs

 

APRIL
30
THURSDAY
6:00 am – 7:00 am
The Gazebo

Morning Fitness Boost

Summit Run, hosted by HealthLine

7:00 am – 6:00 pm
Salon Foyer

Registration Open

7:00 am – 8:00 am
The Monarch Bay Courtyard

Breakfast

7:00 am – 8:00 am
Salon I

Breakfast Session

Profitable Innovation: Invention, Commercialization, Execution
Facilitated by Dentons

Facilitated by: Bruce Fried, Partner, Dentons with panelists: Ronald Kuerbitz, CEO, Fresenius Medical Care North America and Ed Dougherty, Principal, Dentons

Senior executives in every sector of the industry are charged with delivering value. Some need to shorten time to market, others need to produce near term ROI, and others still need to deliver quality healthcare services and improve treatment outcomes in an increasingly price-sensitive environment.

On the eve of the Kentucky Derby, we award the ‘Triple Crown’ to healthcare executives, whose success depends on winning multiple races: being responsive to investors, compliant with regulators and innovators, and delivering affordable, high quality products and services for providers and patients. This session will discuss keys to winning the healthcare triple crown including a baseline model, synthesizing the global clinical and business literature, and testing this model against panelist and audience experience and expertise. Participants will leave with a framework within which to test concepts presented throughout the Summit against the real opportunities and constraints of the business of healthcare.

– Description

General Session: Emerging (and Decaying) Models

8:00 am – 9:00 am
Salons III & IV

The CMS Perspective: Where Do We Go From Here?

Interviewer:
Bruce Bodaken, Visiting Scholar, Brookings Institution and former Chairman and CEO, Blue Shield of California, Summit Chair

Speaker:
Andy Slavitt, Acting Administrator, Centers for Medicare & Medicaid

The Real Deal: Taking on High-Cost, Complex Patients at Scale

Despite challenges, we are seeing an incredible wave of new solutions in caring for populations with multiple chronic diseases, more significant behavioral health issues and complex social situations. Many suspect these solutions will have even more opportunities ahead as they transform individual care. Hear payer, investor and innovator perspectives on what can really be achieved and what new opportunities have yet to be tackled.

Introducer:
Guy Eiferman, Senior Vice President, Strategic Planning and Managing Director, Healthcare Services and Solutions, Merck

Moderator:
Mark D. Smith, MD, MBA, Founding President, California HealthCare Foundation, Summit Chair

Speakers:
Adam Boehler, CEO, Landmark Health
Jay M. Gellert, President and CEO, Health Net, Inc.
Leeba Lessin, President and CEO, CareMore Health System
Thomas A. Scully, General Partner, Welsh, Carson, Anderson & Stowe

10:00 am – 10:30 am
The Monarch Bay Courtyard

Morning Break

10:30 am – 11:20 am
Salons III & IV

Size Matters: New Approaches to National Provider Brands

Even the most notable regional systems face a growth dilemma, causing some to explore innovative approaches to national expansion, unburdened by brick-and-mortar models.  Cleveland Clinic and DaVita HealthCare Partners are on the forefront of these efforts, and others are not far behind.  How are best-of-breed providers thinking about scale, how are they ensuring quality and how will they avoid obstacles seen in past waves?

Introducer:
Kris Joshi, PhD, Executive VP, Products, Emdeon

Moderator:
Michael E. Chernew, PhD, Leonard D. Schaeffer Professor of Health Care Policy and Director, Healthcare Markets and Regulation Lab, Harvard Medical School

Speakers:
Toby Cosgrove, MD, President and CEO, Cleveland Clinic
Kent Thiry, Co-Chairman and CEO, DaVita HealthCare Partners

11:30 am – 12:30 pm

Deep Dive Sessions

Salons II
What the Consumer Really Wants: Data Insights into Purchasing Behavior
Hosted by Aon

Facilitated by Matt Levin, EVP and Head of Global Strategy, Aon and Janet Faircloth, SVP, Strategy and Solutions, Aon

+ Description

Pavilion I
Big Brains on the Internet of Things (IoT)
Hosted by Box

Facilitated by Aneesh Chopra, former CTO, White House, President Obama with panelists: Aaron Levie, CEO, Box; Lee Shapiro, former President, Allscripts and Bill Russell, CIO, St. Joseph Health System

+ Description

Salon I
Transparency of Cost and Quality: Changing Consumer Behavior at Scale?
Hosted by Emdeon

Facilitated by Doug Ghertner, President, Change Healthcare and Jason Gorevic, CEO, Teladoc

+ Description

The Plaza
The Next Holy Grail: Strategic Cost Control
Hosted by Healthagen

Facilitated by Charles Kennedy, MD, Chief Population Health Officer, Healthagen

+ Description

12:30 pm – 2:00 pm
The Monarch Bay Courtyard

Lunch

Topic Tables

+ Description

2:00 pm – 2:50 pm
Salons III & IV

Harnessing the Reality of End-of-Life

End-of-life care accounted for over 28% of Medicare’s budget—or $170B spent in the last six months of life for Medicare beneficiaries alone. According to the Institute of Medicine, enhancing the quality of medical and social services at the end of life would create substantial progress toward a sustainable U.S. health care system. Now more than ever, end-of-life services are becoming a strategic industry priority. Two prominent payers and a health system leader will discuss the most critical issues, where best economics are emerging and potential models for advancing management of end-of-life care.

Moderator:
Alexandra Drane, Co-Founder and Chair of the Board, Eliza Corporation; Co-Founder, Engage with Grace

Speakers:
Mark B. Ganz, President and CEO, Cambia Health Solutions, Summit Chair
Wright R. Lassiter, III, President, Henry Ford Health System
Harold L. Paz, MD, MS, EVP and Chief Medical Officer, Aetna

3:00 pm – 4:00 pm

Deep Dive Sessions

Busting Myths about the 50+: Tracking that Works
Hosted by AARP

Facilitated by Jody Holtzman, SVP Thought Leadership, AARP, with presenter Brad Fain, Principal Research Scientist, Head of the Human Systems Engineering Branch, Georgia Tech Research Institute and panelist Julio Corredor, Director, Worldwide Innovation

+ Description

Salon I

The Complexities of Patient Financial Responsibility
Hosted by Availity

Facilitated by Russ Thomas, CEO, Availity with panelists; Alan Levine, CEO, Mountain States Health Alliance, Rob Coppedge, SVP Strategic Investment and Corporate Development, Cambia Health Solutions, and Sam Khashman, President and CEO, Imagine Software

+ Description

The Plaza
Agile Health – New Models of Care Need New Models of IT
Hosted by CSC

Facilitated by Robert Wah, MD, Chief Medical Officer, CSC, and President of the AMA and Lisa Pettigrew, Industry General Manager, Global Healthcare, CSC

+ Description

Salon II
Zip Code-Driven Health Insights…More Informative than Genetic Code?
Hosted by Optum

Facilitated by Paul Bleicher, MD, PhD, CEO, Optum Labs, and Dave Dickinson, Chief Innovation Officer, Optum Labs

+ Description

4:00 pm – 6:00 pm
The Monarch Bay Courtyard

Afternoon Break

4:15 pm – 5:15 pm
The Terrace Salon

Confab of Women Building Impactful Companies

Join an unmoderated discussion among female healthcare leaders focused on what it takes to build strong teams, how to bring out the best “male” and “female” traits, what “female” traits provide distinct advantages, and what women are getting it done and why.

Speakers:
Gail Boudreaux, Former CEO, UnitedHealthcare
Alexandra Drane, Co-Founder and Chair of the Board, Eliza Corporation; Co-Founder, Engage with Grace
Ann H. Lamont, Managing Partner, Oak HC/FT Partners, Summit Innovation Chair
Lisa Suennen, Managing Partner, Venture Valkyr

6:00 pm – 7:00 pm
Pacific Promenade Lawn

Global Health Reception

7:00 pm – 9:00 pm
The Pacific Promenade

The Big Dinner
Global Disease: How New Investment Priorities Are Changing the Landscape

As the Bill & Melinda Gates Foundation works with its partners to transform lives in developing countries, they are acutely focused on tapping into the talent and resources of the private sector. If Ebola taught us anything, low-cost, sustainable solutions need to be created and delivered to ensure not only local and global health, but also economic viability for all. Enter stage left…opportunity. Sue Desmond-Hellmann will share the business case for the global frontier.

Introducer:
Robert Margolis, MD, CEO Emeritus, HealthCare Partners, Summit Chair

Interviewer:
David Brailer, MD, PhD, Managing Partner and CEO, Health Evolution Partners; Chairman, Health Evolution Summit

Speaker:
Sue Desmond-Hellmann, MD, CEO, Bill & Melinda Gates Foundation

9:00 pm – 11:00 pm
The Plaza

Après

Blackjack and poker overlooking the Pacific.

 

MAY
01
FRIDAY
6:00 am – 7:00 am
The Gazebo

Morning Fitness Boost

Summit Boot Camp

7:00 am – 12:00 pm
Salon Foyer

Registration Open

7:00 am – 8:00 am
The Monarch Bay Courtyard

Breakfast

General Session: Disruptive Models

Disruption is happening in pockets, at varying paces and in a variety of ways. In 2015, the Summit explores where new innovations are seeing landfall and the army of others just behind.

8:00 am – 9:00 am
Salons III & IV

Moon Shots on Health

Moon Shots – big thinking and aiming for breakthroughs instead of incremental improvements – this is the Google[x] mandate. Google has disrupted just about everything we can think of, so what are they up to in health? Will they be the creator or a potential competitor? The former head of the largest health plan in the country shares her perspectives on moon shots…potential profiles, obstacles and how the practical realities of the past may be shifting. Together, this session will raise the stakes and foreshadow areas where we see breakthroughs instead of barriers.

Moderator:
Peter Neupert, Operating Partner, Health Evolution Partners and Former Corporate VP, Microsoft Health Solutions Group, Summit Chair

Speakers:
Gail Boudreaux, Former CEO, UnitedHealthcare
Andy Conrad, PhD, Head of Life Sciences, Google

9:00 am – 9:30 am
Salons III & IV

Consumer On Ramps – Disruptive Models Creating Value

As health care endeavors to engage consumers in their health, some companies are also beginning to create efficiencies, support evolving reimbursement streams and position for value creation. From searching for health information to being monitored remotely; from the healthy consumer to those managing chronic disease or facing acute conditions—the early adopters are contributing to the new health economy. This session will highlight a few innovators disrupting information flow and creating value through the holy grail of the consumer engagement.

Moderator:
Brandon H. Hull, Managing General Partner, Cardinal Partners, Summit Innovation Chair

Speakers:
Eric Rock, CEO, Vivify Health
Ben Wolin, CEO and Co-Founder, Everyday Health

9:30 am – 10:25 am
Salons III & IV

Corporate Venture Takes Hold of Health Care

Creating a corporate venture group is certainly one of the hippest strategies to hit the health industry in years. And while these ventures all hope to capitalize on the next biggest disruption to hit the market, they will not all look the same in their pursuits. Hear what disruptive models are on the horizon, what factors are being considered and what you can expect.

Introducer:
Mark Speers, Partner and Managing Director, Health Advances, LLC

Moderator:
Lisa Suennen, Managing Partner, Venture Valkyrie

Speakers:
Rob Coppedge, SVP Strategic Investment and Corporate Development, Cambia Health Solutions
Dave Schulte, Managing Director, Kaiser Permanente Ventures
David Stevenson, Managing Director, Global Health Innovation Fund, Merck
Rafael Torres, Head of Healthcare, GE Ventures

10:25 am – 10:30 am
Salons III & IV

Comments and Transition to Innovation Activities

Julie Murchinson, CEO, Health Evolution Summit

10:45 am – 1:00 pm
The Plaza

Corporate Venture Action Group

Innovation Activities (concurrent)

Innovators and health leaders roll up their sleeves in an intimate and interactive setting to explore opportunities.

10:40 am – 11:40 am
Salon I

Innovations with Traction: Straight Talk from Customer CEOs

Patient retention and new patient acquisition have always been strategic imperatives, but their importance has risen to mission critical in the transition from fee-for-service to fee-for-value. While these areas may have great impact on both risk of lost revenue and new growth opportunities, they have not been easy problems to solve—and several innovative solutions have stalled. A leading health system CEO talks with innovators about the range of challenges health systems are facing, the approach that different companies are taking and the successes that organizations are experiencing to ensure true value is realized.

Facilitator:
Roy Smythe, MD, Chief Medical Officer, AVIA

Speaker:
Rodney F. Hochman, MD, President and CEO, Providence Health & Services

Innovators:
Mark Hefner, CEO, Infina Connect Healthcare Systems
Oran Muduroglu, CEO, Medicalis

10:40 am – 11:40 am
Pavilion II

Disruption in Progress: Designing for the Consumer

Innovators and health care leaders on the consumer front lines retreat to the boardroom to explore how best to design for the consumer. Innovators are encouraged to roll up their sleeves in this intimate discussion exploring critical needs, while potential payer, provider and retailer customers help to inform design and their approach.

Facilitator:
Joshua Riff, SVP, Consumer Products, Optum

Contributors:
Rushika Fernandopulle, MD, MPP, CEO and Co-Founder, Iora Health
Jeffrey Kang, SVP, Health and Wellness, Services and Solutions, Walgreens Boots Alliance
Tej Shah, SVP, Business Development, Blue Cross Blue Shield of Louisiana

10:40 am – 11:40 am
Pavilion III

Disruption in Progress: Where Life Science Is Headed:
Opportunities Beyond the Pill

Innovators and life science leaders retreat to the boardroom to explore new opportunities beyond the pill. Innovators are encouraged to roll up their sleeves in this intimate discussion exploring critical needs, while potential pharma, biotech and medical device customers inform their solutions and their approach.

Facilitator:
Naomi Fried, PhD, VP of Innovation, Medical Information and External Partnerships, Biogenidec

Contributors:
Guy Eiferman, SVP, Strategic Planning and Managing Director, Healthcare Services and Solutions, Merck
Diego Miralles, MD, Global Head of Innovation, Janssen Pharmaceuticals, Johnson & Johnson
Pascale Witz, EVP, Global Divisions and Strategic Development, Sanofi

11:45 am – 12:45 pm
Pavilion IV

Disruption in Progress: Care Delivery Innovation

Innovators and health care leaders on the front lines of care delivery retreat to the boardroom to explore how to best to design solutions to improve care and reduce cost of delivery. Innovators are encouraged to roll up their sleeves in this intimate discussion exploring critical needs, while provider executives share the value they are seeking and how potential solutions are vetted behind closed doors.

Facilitator:
Molly Coye, MD, Chief Innovation Officer, UCLA Health System

Contributors:
Lyle Berkowitz, MD, FACP, FHIMSS, Associate Chief Medical Officer of Innovation, Northwestern Memorial Hospital
Chip Blaufuss, Assistant VP Strategic Innovation, Hospital Corporation of America
Birthe Dinesen, Professor, Department of Health Science and Technology, Aalborg University (Denmark)
Chuck Dowling, CEO, DiabetesAmerica

11:45 am – 12:45 pm
Pavilion V

Disruption in Progress: Connecting with Capital

Innovators and seasoned investors retreat to the boardroom to connect on the capital landscape: opportunities on the horizon, what investors are seeking, and what they may require in the coming years. Innovators are encouraged to roll up their sleeves in this intimate discussion to ask their burning questions and to hear from the veterans.

Facilitator:
Jodie Emery, Partner Healthcare and Private Equity, Caldwell Partners

Contributors:
Thomas Carella, Managing Director, Merchant Banking Division, Goldman Sachs
Brandon H. Hull, Managing General Partner, Cardinal Partners, Summit Innovation Chair
Noah Knauf, Managing Director, Warburg Pincus
Ravi Sachdev, Partner, Clayton, Dubilier & Rice

OSCAR: THE $1.5B STARTUP MAKING HEALTH INSURANCE SUCK LESS

Overview of a disruptive new entrant to the health insurance sector, fully consolidating the service and value chain with technology.

http://www.wired.com/2015/04/oscar-funding/

THIS $1.5B STARTUP IS MAKING HEALTH INSURANCE SUCK LESS

Mark Bertolini on Preventive Disruption

Excellent interview on a powerful vision for the reinvention of health insurance

http://www.strategy-business.com/article/00324?pg=all

Mark Bertolini’s Preventive Disruption

For Aetna’s CEO, the lauded move to raise employee wages is just part of a broader strategy to adapt to changes in healthcare.

Since January 12, 2015, Aetna chairman and CEO Mark Bertolini has been applauded by the likes of the New Yorker and the Wall Street Journal as an uncommonly forward-thinking and compassionate chief executive — or perhaps just a quixotic one. On that day, he announced a raise in Aetna’s minimum wage to US$16 per hour. For the 5,700 employees who stood to benefit, this meant an average pay increase of 11 percent; some saw an increase of 33 percent. It was arguably the most visible wage hike by a chief executive since 1914, when Henry Ford doubled his assembly line workers’ pay to $5 a day.

The Aetna pay hike was a multifaceted and strategic move — and one that stemmed from personal motivations as well. It also showed Bertolini to be a culturally astute leader with a real stake in improving the well-being of people who rely on Aetna, be they customers, employees, or long-term shareholders. He is also keenly aware of the changing nature of the healthcare industry in the U.S. and elsewhere. Even without the 2010 Affordable Care Act, health insurance companies would have been forced to revise their business models. Consumers have far more choices now than they had even a few years ago, and they approach them in a more conscious, more participative way.

Aetna, which as of 2014 was the third-largest health insurance company in the United States (after UnitedHealth and WellPoint), has been shifting its strategic focus, and its cultural orientation, for several decades. It has evolved from its role as a primarily financially oriented payor to a role as a healthcare solutions provider, helping medical organizations, insurance carriers, and consumers operate in harmony at lower cost. This has resulted in significant changes in the company’s prevalent attitudes and behaviors, with more change to come.

Bertolini is the third Aetna chief executive in a row who has moved the company in this direction. The first was Jack Rowe, chairman and CEO from 2000 through 2006, who turned Aetna around from a declining bureaucracy (with a hidebound culture known to employees as “Mother Aetna”) to a profitable enterprise. Rowe’s successor, Ron Williams, CEO and chairman from 2006 to 2010, restructured the company and paved the way for its return to growth at a time of dramatic industry change. Bertolini, a 58-year-old Detroit native who holds an MBA from Cornell University, joined Aetna as head of specialty products in 2003, and became president in 2007. In this post and as CEO, he has overseen Aetna’s business response to the Affordable Care Act, which helped attune him to Aetna’s complex cultural legacy as well as its potential for change.

Interestingly, the wage raise stemmed directly from Bertolini’s efforts to engage the Aetna company culture, through social media and personal interactions. It was also driven by a wish to be considered among the ethical leaders of American companies. Bertolini “explicitly linked the decision to the broader debate about inequality,” wroteNew Yorker columnist James Surowiecki. “He said that it was not ‘fair’ for employees of a [Fortune 100] company to be struggling to make ends meet.” Even Mother Aetna found it hard to undermine the emotional appeal of this rationale.

Bertolini is known for his no-nonsense, energetic style; his ability to mix formal and informal leadership; his advocacy of preventive medicine (after using yoga to recover from a debilitating ski accident in 2004, he introduced it to Aetna employees and ultimately to customers); and his penchant for speaking candidly and off the cuff. In this interview, conducted in two sessions in his Hartford, Conn., offices — the first in August 2014 and the second in January 2015, just after the wage announcement — he spells out the reasons for the pay and benefits change, the reaction it evoked in the company’s culture, and the connection to Aetna’s audacious strategic goal of becoming one of the few payor companies with a profitable and influential leadership position in the emerging healthcare industry.

S+B: How did you come to the wage hike decision?
BERTOLINI:
When I took this job as CEO, I had three objectives. One was to set Aetna on a course for the next 160 years. Our purpose should be to become a consumer company. The second was to make healthcare reform actually work. The third was to reestablish the credibility of corporate leadership in the eyes of the American public.

S+B: Not just for Aetna, but for every company?
BERTOLINI:
Yes. But at Aetna, this meant having a style of leadership that was approachable, real, and tangible. One of my goals was cultural impact. I told the PR team, “You cannot protect me; you must prepare me. So get ready. I’m going to go out there and speak truthfully, and talk about how to move forward.” That approach has served me well.

“I told the PR team, “You cannot protect me; you must prepare me.”

I became active on social media. We have an internal network called Aetna Connect, and I’m constantly talking to the employees on it. They also talk to each other. More and more often, I saw people online saying, “I can’t afford my benefits. My healthcare coverage is too expensive.”

I heard the same thing in site visits. When I visit an Aetna office, after the town meeting where I speak, I try to go to every cubicle in the building and shake everybody’s hand. I ask them what they’re up to and how they feel about it here. The same message came through.

At the same time, I could see that the economic recovery was unequal. People were suffering, but capital was cheap and corporations were hoarding cash and not investing. Business leaders were saying, “When the government gets its act together, we’ll move forward [with helping low-income wage earners].”

Then Thomas Piketty’s Capital in the Twenty-First Century [Belknap Press, 2014] came out. I know a number of well-known economists, and they all leaned the same way. There is pressure to fix this [income inequality] problem through the law of the land. That was a scary prospect: massive wealth redistribution through the federal government. We needed to prevent that.

Another influence was Clayton Christensen. He and I have been working together since 2011. Clay’s basic idea is that companies should husband scarce resources and put plentiful resources at risk. In our current environment, the scarcest resource is talent: human capital, not financial capital. Companies have cash sitting on balance sheets around the world. It makes more sense to spend the money on people than on acquisitions.

S+B: What did the business leaders within Aetna think?
BERTOLINI:
They were also starting to agitate about the income inequality problem. Some of them were worried about turnover, and being able to keep people motivated on the front line. After we had looked at a number of options to help our lowest-paid employees, I finally said, “How about we just pay them more?”

[Aetna chief of staff] Steve Kelmar is my sounding board. When he said the organization was ready to make this kind of change, we got a team together. First, we needed more data. I asked the HR team to build a profile: How much did the lowest-paid people at Aetna make? What did their healthcare coverage look like? What were their out-of-pocket costs? How hard was it for them to get by?

It took months to get this information. The organization really wasn’t ready to talk about it, but I kept pushing. Ultimately, we determined that a raise to $16 per hour would cost us $10.5 million per year. So I asked for data on the business impact. Our accepted figure for turnover costs was $27 million per year, but that was only voluntary turnover. I asked for total turnover costs. How many people leave involuntarily? How much does it cost to hire their replacements? How long does it take to train the new recruits? We looked at absenteeism, rework, productivity, dissatisfied employees, and our net promoter scores [a measure of survey respondents’ enthusiasm] in recruiting new employees. Incidentally, our industry’s general net promoter scores are below those of airlines and cable TV companies.

We figured out that our total turnover costs were $120 million per year. By that measure, $10.5 million looked like a low-risk investment. We [had] also recently hired a new head of human resources to partner with me on doing the right thing.

S+B: How many employees were affected by this policy?
BERTOLINI:
About 5,700 employees got wage increases to $16 per hour. Most of them were call center employees; some were single mothers or fathers, and others had children on Medicaid because they couldn’t afford our dependent coverage.

It wasn’t enough to just increase their wages; we also had to do something about their medical benefits. I talked to economists at the Peterson Institute for International Economics, where I’m on the board, and they pointed out that wage increases can affect benefits negatively [by reducing subsidies]. So we reduced the cost sharing on their benefits. This gave many of them our richest benefit plan at the price of our least rich plan — a zero premium cost for many of our frontline employees. Our objective was to raise the personal disposable income [PDI, or income after taxes, benefits, and other withholdings] of this population as high as we could without breaking the bank.

S+B: This wasn’t a cascading measure where you’d also raise other wages through the company.
BERTOLINI:
There was a huge gap between the people making $13 to $14 per hour and the rest of the company. People at the next higher salary level didn’t have the same issues.

When we made the change, some people saw a 33 percent increase in wages and a 45 percent increase in PDI. We also added another element to our social compact by offering certain employees enhanced medical benefits based on household income and their commitment to engage in certain wellness programs.

A Proud Moment

S+B: What was the announcement like?
BERTOLINI:
I went down to our largest call service center in Jacksonville, Fla., to announce it on January 12. We had to get a hotel ballroom to fit everyone in. Everybody was wondering why I was there. “He’s retiring.” “The company’s been sold.”

Very few people knew in advance. I had given the Wall Street Journal an exclusive interview the week before but embargoed the story until that evening. I wanted the employees to hear about it from me directly. We had also given our top 300 managers a heads-up the day before; we got them on the phone. They said things like “This is the proudest moment I’ve had in 42 years at the company.”

Then I made the announcement, and the place exploded. I had known people would be happy, but I wasn’t ready for the raw emotion. There were people crying. People saying, “Praise the Lord. My prayers have been answered.” The frontline managers were thrilled.

S+B: Were there negative reactions?
BERTOLINI:
Some employees said, “Wait a minute. I worked six years to get to $16 per hour and here you are handing it to them. What are you going to do for me?” It was disappointing to hear this.

S+B: How did you deal with cultural resistance?
BERTOLINI:
I kept control of [the initiative]. I brought the senior team into it because everyone would have to implement it, but I stayed closely involved myself.

S+B: What was the reaction from the shareholders?
BERTOLINI:
They’ve been largely supportive, with many going out of their way to ask about the move and voice their approval. Many of those who were concerned about the potential financial impact quickly became supportive when they came to understand the total magnitude of the enterprise impact, versus the benefits in employee satisfaction and retention.

Of course, all along I’ve been trying to move our shareholder base to long-term investors who will be more supportive of the changes we need to make to succeed in the new healthcare environment.

As Clayton Christensen points out, the shareholder formula in most companies is much too tightly connected to earnings per share. And you know what? Shareholders do not directly benefit from earnings per share increases. They get the difference in the value they bought at versus the value they sell at. What drives that stock price? It’s Wall Street’s belief about whether we have a sustainable product that our customers consistently buy. This is reflected in the P/E ratio.

Aetna’s earnings per share have grown at 15.5 percent for the last five years. But our total shareholder return grew 207 percent [during the same period]. What changed? The P/E. The magic question is: Are your business fundamentals sound enough that you can consistently deliver a product that customers will continue to buy over time? If people believe our business fundamentals are sustainable, it will move the stock price higher. This should be the way we think about it.

S+B: Not many company leaders have that kind of confidence.
BERTOLINI:
In the summer of 2009, we missed our plan by $450 million. I was president. I asked [CEO] Ron Williams, “Why haven’t you put a bullet in me?”

He said there were three reasons. “One, you’re running the place, and I can’t get rid of you. Two, you’ve hopped on the problem, and the plans look great. And three, nobody’s ever going to really be successful as a Fortune 100 CEO until he or she faces one of these crises and actually fixes it. So, finish it up and you’ll be the next CEO.”

You always have the opportunity to lead, no matter what your title. I never let the lack of a title get in my way; when I found a leadership vacuum, I’d jump in. When I talk to my direct reports and they say they don’t have the authority to do something, I say, “Here’s a secret: Do it anyway.” They’ll say, “Well, that’s not my job.” I say, “Yeah, it is.”

“I never let the lack of a title get in my way; when I found a leadership vacuum, I’d jump in.”

Culture and Behavior

S+B: You’re the third CEO in a row trying to create a culture of productivity and accountability at Aetna. How do you see those efforts?
BERTOLINI:
I don’t think you can create a culture. A culture emerges and evolves slowly over time. It’s a bit like a Petri dish. You hope the conditions are good for the right culture to grow. You try to get as much help as possible from the current cultural situation. Fortunately, it is seldom all good or all bad. At the end of the day, my biggest challenge has been to show the organization that it is necessary to take something apart while it’s successful, in order to make it even better. That is one of the theories of creative destruction.

S+B: What’s an example of the behaviors you’re trying to change?
BERTOLINI:
A lot of it has to do with improving accountability. This is a real issue when shifting from a command-and-control organization to an organization where people make important decisions at all levels. But you cannot change that all at once, so you work on a few key behaviors at a time.

One example is the way we manage meetings. In 2008, I added up the number of days I had to spend in major internal meetings. It was 180 out of about 200. We had a staff of 250 people who did nothing but put PowerPoints together for such meetings. So we set a goal of 70 percent less paper, 10 percent fewer meetings, and 50 percent fewer people attending. You should attend only meetings where you’re needed to make a decision, not to learn about [the topics].

“We set a goal of 70 percent less paper, 10 percent fewer meetings, and 50 percent fewer people attending.”

At first, people were upset: “Why am I no longer invited?”

“Well, you were grousing about having to sit in the back row doing emails. Go see a customer instead.”

We just had our monthly results meeting; there were 15 people in the room. Prior to this change, it would have been 80.

S+B: How do these changes affect customers?
BERTOLINI:
The healthcare industry is going through yet another major change. It will be a retail business before too long. By 2020, more than 75 million people will be purchasing insurance directly. That’s why Aetna became one of the largest players in Affordable Care Act exchanges — a move that surprised everybody. Those markets are blossoming for us, because people really want safety. They’re not saying, “I can’t wait to get insurance so I can run off to the doctor and spend somebody else’s money.” They’re solid working people trying to take care of their families. I want us to really care about those people.

When I was growing up, my dad worked as a pattern maker in the auto industry. Since the models changed every five years, he only worked six months every year. My mother was a nurse in a pediatrician’s office. That’s how we got our healthcare paid for. Our market is families like that.

The Affordable Care Act will commoditize this industry. That gives companies two options. They can put their thumb in their mouth, cut their costs, and hope they’re the last company standing. Or they can focus on the two or three parts of the business that have the most value, let the rest disappear, and repurpose their businesses accordingly.

We chose the second option — to focus on a critical few elements. So what could we leverage? Where do we have an emotional as well as a rational advantage? One was our reputation with healthcare providers, including hospitals. They think highly of us, and they all want to get in the insurance business, so why don’t we create a franchise kit for them? We built Healthagen [a line of health management, information technology, and related services for healthcare providers]. When we started working on it in 2005, we called it “Health Plan in a Box.”

We also built a clinical capacity exchange called WellMatch, which lets us resell excess capacity in the healthcare system — services like imaging, lab tests, office visits, and flu shots. And we’re making investments in new technologies, like iTriage [a health literacy and self-care app] and Medicity [which has a network of more than 1,000 hospitals, 270,000 healthcare professionals, and 20 regional and statewide health information exchanges connected to it]. Those two acquisitions were not on the market. We went and talked to them and bought them, and they’ve been very successful. But neither acquisition would have been made with a purely financial or data-driven rationale. We did them because we believed in them.

To make this work, we need to be willing to share our intellectual property and our technology. We can even let providers use it for free. If Healthagen technology helps people buy healthcare more intelligently, or gets them to the right doctor, or stops them from having to go to the emergency room, that helps our customers and it helps our business. Aetna’s medical costs in 2014 were over $40 billion. If we can reduce the annual rate of increase in medical costs by 50 basis points, that’s over $200 million of potential incremental underwriting margin.

We have begun to build accountable care organizations (ACOs) for providers. We are helping them evolve from a revenue-based model to margin-based insurance. We hired executive vice president Dijuana Lewis from Walmart, where she ran the healthcare vertical, to create a retail business for these organizations. The other two major parts of the enterprise are Healthagen, the provider-facing business, run by senior executive vice president Joe Zubretsky; and the core institutional business, run by president Karen Rohan, effective January 2015. From the combination of these three units, we are building, in essence, a fundamentally different value proposition in the marketplace; it is a population health model, in which providers get rewarded for keeping people well. Eventually, instead of primarily being a health insurance company, we’ll be like “Intel Inside,” providing the common infrastructure.

A Next-Generation Payor

S+B: What do you need to do to go down that road?
BERTOLINI:
First and foremost, we have to make provider relationships work over the long term. For employers to give up their ability to put health benefits directly in employees’ hands, they have to believe that the costs will be sustainable and affordable over time.

The best shot is to get providers engaged in population health. We will need to work with them in a variety of ways: fee-for-service systems, clinical efficiency, avoiding readmissions, and supply chain efficiency. Buying coalitions to lower the prices of drugs, stents, and wheelchairs. Giving them access to capital markets, debt and equity, to build their capacity to meet the needs of the full community. We want to make it easy for them to do the right thing for their customers.

I use Tesla as an analogy. Elon Musk has a car that runs purely on electricity, but it’s constrained by a lithium ion battery that represents 65 percent of the cost, and the car costs $85,000. So he builds a factory to reinvent the battery. If he can get to a $35,000 electric car and if free charging is everywhere, he can turn the energy and automotive industries upside down. Similarly, the healthcare provider system represents 85 percent of our cost. Unless we reinvent that system, we can’t begin to make it a retail proposition.

S+B: What does this change mean for the people of the company?
BERTOLINI:
There are three kinds of people at Aetna. There are people who want to operate under the old model, and they probably have five or 10 years left before that model is obsolete. But they are generating the capital that will fund the transition.

A second group is focused on the new stuff. Many of them work at Healthagen, whose offices are in Salt Lake City, Silicon Valley, and Denver. They largely came out of venture capital and private equity. When I go see them, it feels very natural to wear jeans and Birkenstocks or cowboy boots. It’s a completely different style of enterprise and cultural situation.

The third group is people who are involved in the old businesses, and who need help making the transition to the new world. The new model will need a lean operating infrastructure, so we will need to prepare for that. But we’ll also need new kinds of roles. For example, we’ll need to find roles for people in case management, marketing, and other fields where we haven’t needed many people before. Our budget in 2018 for consumer advertising might be 10 times what it is today.

S+B: Does everybody at the company understand the need for change?
BERTOLINI:
We’re talking about a lot of change. Some people have been with the company for a long time, and their attitude is: “What are you doing?”

At a leaders’ meeting, one manager said, “Mark, why are we making such significant change? The company has had record earnings, revenue, membership, and stock price.”

I was really surprised by that. I said, “Then all this talk about what’s going on in the marketplace, you believe all of that’s just fake?”

We had just done an employee engagement survey and the lowest scores were from people like those in the room, two levels below me. As you look at the survey results down through the organization, the scores rose again, and the frontline employees were among the most engaged. So I said, “45 percent of the people in this room really don’t want to be here. So why are you here? Why are you wasting your time and mine?”

The dialogue for the next hour was amazing. People talked about how hard it was to change, how they just wanted to do their jobs. At the end, I said, “I really appreciate everyone’s honesty. But I’m not going away. This is going to happen. Look to your left and right and decide. If you want to be here, we want you.”

S+B: How do you find and cultivate the people who are enthusiastic about change?
BERTOLINI:
I’m working now with the top 300 people, looking for a group of about 120 who can be informal leaders — people whose influence does not just depend on their position in the hierarchy. That will probably get honed down to a smaller group. Eventually I would like to have a kitchen cabinet of people who are authentic informal leaders drawn from all layers of the company.

I’m also continuing to use social media. I actually write my own tweets [he’s @mtbert]. My most widely recognized exchange on social media was with @PoopStrong [the Twitter handle and website of Arijit Guha, a graduate student at Arizona State University who was diagnosed with stage IV colon cancer, and began fundraising online when the costs of his care exceeded the benefits limit on his Aetna policy — Bertolini intervened directly in his case]. Sadly, Mr. Guha passed away, but we solved the benefits problem, and that was important to a lot of people, inside and outside the organization.

Most people think it’s hard to find the time to manage social media. But people talk to one another. I don’t even need to interject. I just watch it go on. I know I’m going to get attacked at times; people will say unfair things about me. But I think it’s much more efficient than email. I have 7,000 emails in my inbox, and I respond to virtually none of them. But with internal social media, we can create real teams. Eventually I’d like to replace email altogether with social media.

S+B: You have another project called “reinventing capitalism.” What’s involved in that?
BERTOLINI:
I am connected with a group of chief executives at Harvard’s Center for Higher Ambition Leadership. [Harvard professor emeritus] Michael Beer wrote a book about it. We started five years ago with five CEOs, and there are now 40 of us. We’re talking about how we can combine social and financial value — and what we need in the way of metrics to create better companies.

At our last meeting, in January 2015, I talked about this wage initiative. There are now 30 other CEOs who want to do something similar. Some of them have started, and it’s already clear they have the same hurdles to overcome. Even in companies where they talk about values and culture all the time, when asked what the lowest-paid group in their workforce looks like, [the staff will] tell you they don’t know and they don’t have the data. You have to learn to persevere with or without data. That’s how you have impact.

AUTHOR PROFILES:

  • Jon R. Katzenbach is a senior executive advisor with Strategy& based in New York, and co-leads the Katzenbach Center’s cultural initiatives.
  • Gretchen Anderson is a principal with Strategy& and a director of the Katzenbach Center.
  • Art Kleiner is editor-in-chief of strategy+business.

 

PAGE 1 2 3 4 5 6 7 8  | ALL